Found: 9
Select item for more details and to access through your institution.
Mesenchymal stromal cells; a new horizon in regenerative medicine.
- Published in:
- Journal of Cellular Physiology, 2020, v. 235, n. 12, p. 9185, doi. 10.1002/jcp.29803
- By:
- Publication type:
- Article
Quercetin sensitizes human myeloid leukemia KG‐1 cells against TRAIL‐induced apoptosis.
- Published in:
- Journal of Cellular Physiology, 2019, v. 234, n. 8, p. 13233, doi. 10.1002/jcp.27995
- By:
- Publication type:
- Article
Leukemia therapy by flavonoids: Future and involved mechanisms.
- Published in:
- Journal of Cellular Physiology, 2019, v. 234, n. 6, p. 8203, doi. 10.1002/jcp.27628
- By:
- Publication type:
- Article
CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies.
- Published in:
- Stem Cell Research & Therapy, 2021, v. 12, n. 1, p. 1, doi. 10.1186/s13287-021-02462-y
- By:
- Publication type:
- Article
Comorbidities and mortality rate in COVID‐19 patients with hematological malignancies: A systematic review and meta‐analysis.
- Published in:
- Journal of Clinical Laboratory Analysis, 2022, v. 36, n. 5, p. 1, doi. 10.1002/jcla.24387
- By:
- Publication type:
- Article
Humanized Culture Medium for Clinical-Grade Generation of Erythroid Cells from Umbilical Cord Blood CD34+ Cells.
- Published in:
- Advanced Pharmaceutical Bulletin, 2021, v. 11, n. 2, p. 335, doi. 10.34172/apb.2021.031
- By:
- Publication type:
- Article
The Effect of Platelet Lysate on Expansion and Differentiation Megakaryocyte Progenitor Cells from Cord Blood CD34<sup>+</sup> enriched Cells.
- Published in:
- Iranian Journal of Pediatric Hematology & Oncology, 2021, v. 11, n. 3, p. 172, doi. 10.18502/ijpho.v11i3.6563
- By:
- Publication type:
- Article
Kaempferol sensitizes tumor necrosis factor-related apoptosis-inducing ligand-resistance chronic myelogenous leukemia cells to apoptosis.
- Published in:
- Molecular Biology Reports, 2022, v. 49, n. 1, p. 19, doi. 10.1007/s11033-021-06778-z
- By:
- Publication type:
- Article
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons.
- Published in:
- Cell Communication & Signaling, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12964-022-00854-y
- By:
- Publication type:
- Article